期刊
CHEMMEDCHEM
卷 6, 期 7, 页码 1152-1162出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/cmdc.201000538
关键词
antagonists; dopamine D-3 receptors; HERG; medicinal chemistry; neurological agents; Positron emission tomography (PET)
Dopamine (DA) D-3 receptor antagonism might play a significant role in different therapeutic areas. A high number of preclinical studies on DA D-3 receptor antagonists have shown efficacy in animal models of Parkinson's disease, schizophrenia and drug dependence. This Review covers the activities of medicinal chemists in this field over the last ten years towards the identification of truly selective compounds. Both primary and patent literature is reviewed here. Since the original discoveries, a clear trend towards the optimization of the developability properties of the new scaffold has clearly emerged with time, from both academic and industrial researchers. Examples of advanced leads from academia and industry are described. The latest potential therapeutic applications are reported too.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据